Trials / Completed
CompletedNCT05135923
Glutenfree, Gut Microbiota and Metabolic Regulation
The Effect of Gluten-free Diet on Gut Microbiota and Metabolic Regulation in People With Coeliac Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Oslo Metropolitan University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
High intake of dietary fiber provides health benefits and reduces the risk of developing cardio-metabolic diseases, such as type 2 diabetes (T2D) and cardiovascular disease (CVD). The intake of fiber is below the recommendations worldwide. In Norway, bread and cereals represent a major source of fiber. A low fiber intake is evident for people with celiac disease due to the removal of wheat, rye and barley from the diet. We therefore need to increase our knowledge in relation to fiber-rich food that will be tolerated also by people with celiac disease. The aim of the study is to investigate the effect of fiber rich gluten free products on blood glucose levels compared to benchmark gluten free products.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Randomized, controlled trial (RCT) with parallel arms and double blinded | Experiment group receive optimized gluten free products (high in fiber and whole grain) compared to comparable benchmark gluten free products (control group). |
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2021-11-26
- Last updated
- 2024-08-12
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT05135923. Inclusion in this directory is not an endorsement.